Assignee profile:

INTERMUNE ,INC.

City:

Brisbane, California

Country:

United States

Published Applications:

88

Last publication date:

2017-04-06

Patent Grants:

47

Last grant date:

2018-07-03

Top Inventors for applications by INTERMUNE ,INC.

These are the the leading inventors for applications assigned to INTERMUNE ,INC.:

Recent patent applications by INTERMUNE ,INC.

INTERMUNE ,INC. based in Brisbane, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2017-04-06 ✅ Patent 10,010,536 granted on 2018-07-03
US20170095462A1
Human necessities

Method of modulating stress-activated protein kinase system

#2 | 2016-09-15 ✅ Patent 9,675,593 granted on 2017-06-13
US20160263090A1
Human necessities

Anti-fibrotic pyridinones

#3 | 2016-03-17 ✅ Patent 9,561,217 granted on 2017-02-07
US20160074375A1
Human necessities

Pharmaceutical composition containing as an active ingredient 5-methyl-1-phenyl-2-(1H)-pyridone

#4 | 2016-01-28 ✅ Patent 9,682,071 granted on 2017-06-20
US20160022654A1
Human necessities

Methods of improving microvascular integrity

#5 | 2015-06-18
US20150164874A1
Human necessities

PIRFENIDONE AND ANTI-FIBROTIC THERAPY IN SELECTED PATIENTS

#6 | 2014-09-25 ✅ Patent 9,726,677 granted on 2017-08-08
US20140286929A1
Physics

Proteomic IPF markers

#7 | 2014-08-28
US20140242159A1
Human necessities

Method for Preparing a Granulate Formulation of Pirfenidone and Pharmaceutically Acceptable Excipients

#8 | 2014-08-21 ✅ Patent 9,290,450 granted on 2016-03-22
US20140235637A1
Chemistry; metallurgy

Compounds and methods for treating inflammatory and fibrotic disorders

#9 | 2014-08-14 ✅ Patent 9,527,816 granted on 2016-12-27
US20140228310A1
Chemistry; metallurgy

Method of modulating stress-activated protein kinase system

#10 | 2014-08-07
US20140221660A1
Chemistry; metallurgy

METHOD FOR SYNTHESIZING PIRFENIDONE

#11 | 2014-08-07
US20140221434A1
Human necessities

ALTERING PHARMACOKINETICS OF PIRFENIDONE THERAPY

#12 | 2014-03-13
US20140073673A1
Human necessities

Pirfenidone Treatment for Patients with Atypical Liver Function

#13 | 2014-03-06 ✅ Patent 8,778,947 granted on 2014-07-15
US20140066484A1
Human necessities

Methods of administering pirfenidone therapy

#14 | 2013-12-26
US20130345430A1
Chemistry; metallurgy

METHOD FOR SYNTHESIZING PIRFENIDONE

#15 | 2013-08-29
US20130225639A1
Human necessities

ALTERING PHARMACOKINETICS OF PIRFENIDONE THERAPY

#16 | 2013-08-29
US20130220871A1
Human necessities

METHOD OF PROVIDING PIRFENIDONE THERAPY TO A PATIENT

#17 | 2013-06-27 ✅ Patent 8,753,679 granted on 2014-06-17
US20130165484A1
Human necessities

Capsule formulation of pirfenidone and pharmaceutically acceptable excipients

#18 | 2013-06-13
US20130150426A1
Chemistry; metallurgy

METHODS OF DIAGNOSING AND TREATING IDIOPATHIC PULMONARY FIBROSIS

#19 | 2013-05-09 ✅ Patent 9,017,722 granted on 2015-04-28
US20130115288A1
Human necessities

Pharmaceutical composition containing as an active ingredient 5-methyl-1-phenyl-2-(1H)-pyridone

#20 | 2013-04-25 ✅ Patent 8,969,347 granted on 2015-03-03
US20130102597A1
Chemistry; metallurgy

Compounds and methods for treating inflammatory and fibrotic disorders

#21 | 2013-03-21 ✅ Patent 8,975,235 granted on 2015-03-10
US20130072449A1
Chemistry; metallurgy

Lysophosphatidic acid receptor antagonists

#22 | 2013-02-21 ✅ Patent 8,754,109 granted on 2014-06-17
US20130045997A1
Human necessities

Pirfenidone therapy and inducers of cytochrome P450

#23 | 2013-01-31
US20130030024A1
Human necessities

Method of Administering Pirfenidone Therapy

#24 | 2012-10-11 ✅ Patent 8,741,936 granted on 2014-06-03
US20120258924A1
Human necessities

Method of modulating stress-activated protein kinase system

#25 | 2012-08-16 ✅ Patent 8,299,021 granted on 2012-10-30
US20120208995A1
Chemistry; metallurgy

Macrocyclic inhibitors of hepatitis C virus replication

#26 | 2012-04-26
US20120101032A1
Chemistry; metallurgy

NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION

#27 | 2012-04-19
US20120095211A1
Chemistry; metallurgy

SUBSTITUTED PROLINE INHIBITORS OF HEPATITIS C VIRUS REPLICATION

#28 | 2012-04-19
US20120094897A1
Chemistry; metallurgy

NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION

#29 | 2012-04-12 ✅ Patent 8,648,098 granted on 2014-02-11
US20120088801A1
Human necessities

Pirfenidone therapy and inducers of cytochrome P450

#30 | 2012-03-29 ✅ Patent 8,592,462 granted on 2013-11-26
US20120077850A1
Human necessities

Pirfenidone treatment for patients with atypical liver function

#31 | 2012-02-23
US20120046321A1
Human necessities

METHODS OF TREATING ATRIAL FIBRILLATION WITH P38 INHIBITOR COMPOUNDS

#32 | 2012-01-19 ✅ Patent 8,519,140 granted on 2013-08-27
US20120016133A1
Chemistry; metallurgy

Method for synthesizing pirfenidone

#33 | 2012-01-19
US20120015985A1
Human necessities

Methods of Administering Pirfenidone Therapy

#34 | 2012-01-19 ✅ Patent 8,383,150 granted on 2013-02-26
US20120015984A1
Human necessities

Granulate formulation of pirfenidone and pharmaceutically acceptable excipients

#35 | 2012-01-19
US20120014917A1
Human necessities

METHODS OF TREATING HIV PATIENTS WITH ANTI-FIBROTICS

#36 | 2011-12-29 ✅ Patent 8,318,780 granted on 2012-11-27
US20110319453A1
Human necessities

Methods of administering pirfenidone therapy

#37 | 2011-12-22
US20110312996A1
Chemistry; metallurgy

NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION

#38 | 2011-10-27 ✅ Patent 8,609,701 granted on 2013-12-17
US20110263656A1
Human necessities

Pirfenidone treatment for patients with atypical liver function

#39 | 2011-09-08
US20110218169A1
Human necessities

Pirfenidone/Toll-Like Receptor (TLR) Agonist Compounds and Methods of Treating Neutropenia

#40 | 2011-07-21
US20110177026A1
Human necessities

Use of Alpha-Glucosidase Inhibitors to Treat Alphavirus Infections

#41 | 2011-07-14 ✅ Patent 8,084,475 granted on 2011-12-27
US20110172277A1
Human necessities

Pirfenidone therapy and inducers of cytochrome P450

#42 | 2011-07-07 ✅ Patent 8,013,002 granted on 2011-09-06
US20110166186A1
Human necessities

Methods of administering pirfenidone therapy

#43 | 2011-06-23
US20110152246A1
Chemistry; metallurgy

NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION

#44 | 2011-06-09
US20110136876A1
Human necessities

Altering Pharmacokinetics of Pirfenidone Therapy

#45 | 2011-06-02
US20110129444A1
Human necessities

NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION

#46 | 2011-05-12
US20110110890A1
Chemistry; metallurgy

Novel Inhibitors of Hepatitis C Virus Replication

#47 | 2011-04-07
US20110082182A1
Chemistry; metallurgy

THERAPEUTIC ANTIVIRAL PEPTIDES

#48 | 2011-04-07
US20110081315A1
Chemistry; metallurgy

NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION

#49 | 2011-03-22 ✅ Patent 7,910,610 granted on 2011-03-22
US12901245
-

Methods of administering pirfenidone therapy

#50 | 2011-03-10
US20110059047A1
Chemistry; metallurgy

NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION

#51 | 2011-02-10
US20110034495A1
Chemistry; metallurgy

Method of Modulating Stress-Activated Protein Kinase System

#52 | 2011-01-06
US20110003863A1
Chemistry; metallurgy

METHOD FOR SYNTHESIZING PIRFENIDONE

#53 | 2010-12-23 ✅ Patent 8,420,674 granted on 2013-04-16
US20100324097A1
Human necessities

Method of providing pirfenidone therapy to a patient

#54 | 2010-10-19 ✅ Patent 7,816,383 granted on 2010-10-19
US12684879
-

Methods of administering pirfenidone therapy

#55 | 2010-09-02 ✅ Patent 8,735,345 granted on 2014-05-27
US20100221217A1
Human necessities

Therapeutic composition

#56 | 2010-08-19
US20100209391A1
Chemistry; metallurgy

NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION

#57 | 2010-06-17 ✅ Patent 7,988,994 granted on 2011-08-02
US20100152250A1
Human necessities

Capsule formulation of pirfenidone and pharmaceutically acceptable excipients

#58 | 2010-06-17 ✅ Patent 7,932,267 granted on 2011-04-26
US20100150867A1
Human necessities

Use of α-glucosidase inhibitors to treat alphavirus infections

#59 | 2010-05-13
US20100119479A1
Chemistry; metallurgy

THERAPEUTIC ANTIVIRAL PEPTIDES

#60 | 2009-12-24 ✅ Patent 8,304,413 granted on 2012-11-06
US20090318455A1
Chemistry; metallurgy

Compounds and methods for treating inflammatory and fibrotic disorders

#61 | 2009-12-22 ✅ Patent 7,635,707 granted on 2009-12-22
US12553292
-

Pirfenidone treatment for patients with atypical liver function

#62 | 2009-12-03 ✅ Patent 7,932,277 granted on 2011-04-26
US20090297476A1
Chemistry; metallurgy

Peptide inhibitors of hepatitis C virus replication

#63 | 2009-10-29 ✅ Patent 8,048,862 granted on 2011-11-01
US20090269305A1
Chemistry; metallurgy

Macrocyclic inhibitors of hepatitis C virus replication

#64 | 2009-10-15
US20090257979A1
Chemistry; metallurgy

Novel Inhibitors of Hepatitis C Virus Replication

#65 | 2009-09-03
US20090220943A1
Chemistry; metallurgy

HCV GENOTYPING AND PHENOTYPING

#66 | 2009-08-06 ✅ Patent 7,696,236 granted on 2010-04-13
US20090197923A1
Human necessities

Method of providing pirfenidone therapy to a patient

#67 | 2009-07-30 ✅ Patent 7,767,225 granted on 2010-08-03
US20090191265A1
Human necessities

Capsule formulation of pirfenidone and pharmaceutically acceptable excipients

#68 | 2009-07-28 ✅ Patent 7,566,729 granted on 2009-07-28
US12428393
-

Modifying pirfenidone treatment for patients with atypical liver function

#69 | 2009-07-02
US20090169510A1
Chemistry; metallurgy

NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION

#70 | 2009-06-11
US20090148407A1
Chemistry; metallurgy

Novel Macrocyclic Inhibitors of Hepatitis C Virus Replication

#71 | 2009-04-09 ✅ Patent 8,119,592 granted on 2012-02-21
US20090093533A1
Chemistry; metallurgy

Compounds and methods for inhibiting hepatitis C viral replication

#72 | 2009-02-19
US20090047246A1
Chemistry; metallurgy

NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION

#73 | 2008-11-20
US20080287508A1
Human necessities

ALTERING PHARMACOKINETICS OF PIRFENIDONE THERAPY

#74 | 2008-08-14 ✅ Patent 7,767,700 granted on 2010-08-03
US20080194644A1
Human necessities

Method of providing pirfenidone therapy to a patient

#75 | 2008-05-01
US20080102056A1
Human necessities

Marketing System for Improving Patient Compliance and Methods and Devices Relating to Same

#76 | 2008-01-24 ✅ Patent 7,781,474 granted on 2010-08-24
US20080019942A1
Chemistry; metallurgy

Inhibitors of hepatitis C virus replication

#77 | 2008-01-03
US20080003635A1
Physics

High Throughput Collagen Synthesis Assay

#78 | 2007-05-24 ✅ Patent 7,407,973 granted on 2008-08-05
US20070117841A1
Human necessities

Use of pirfenidone in therapeutic regimens

#79 | 2007-04-26
US20070092488A1
Physics

Methods of treating idiopathic pulmonary fibrosis

#80 | 2007-03-08 ✅ Patent 7,829,665 granted on 2010-11-09
US20070054842A1
Chemistry; metallurgy

Macrocyclic inhibitors of hepatitis C virus replication

#81 | 2007-03-08
US20070053877A1
Human necessities

Methods of treating idiopathic pulmonary fibrosis

#82 | 2006-11-30 ✅ Patent 7,728,013 granted on 2010-06-01
US20060270612A1
Human necessities

Method of modulating stress-activated protein kinase system

#83 | 2006-11-30 ✅ Patent 7,638,488 granted on 2009-12-29
US20060269517A1
Human necessities

Use of alpha-glucosidase inhibitors to treat alphavirus infections

#84 | 2005-12-01 ✅ Patent 7,491,794 granted on 2009-02-17
US20050267018A1
Chemistry; metallurgy

Macrocyclic compounds as inhibitors of viral replication

#85 | 2005-08-30 ✅ Patent 6,936,695 granted on 2005-08-30
US8462022
-

Manufacture and expression of large structural genes

#86 | 2005-08-30 ✅ Patent 6,936,694 granted on 2005-08-30
US6483451
-

Manufacture and expression of large structural genes

#87 | 2005-03-17
US20050058644A1
Human necessities

Combination therapy of gamma-interferon and B-cell specific antibodies

#88 | 2005-02-17 ✅ Patent 6,939,947 granted on 2005-09-06
US20050037950A1
Chemistry; metallurgy

N1-modified glycopeptides

Also check out Intermune, Inc.'s (Brisbane, United States) applicant profile with 10 patent applications submitted.

AssigneeID:

7372 ⎘